<img alt="" height="1" width="1" />
Vertex cystic fibrosis combo shows promise
NEW YORK (Reuters) - A combination of two experimental drugs from Vertex Pharmaceuticals Inc showed promise for cystic fibrosis patients in the first part of a midstage study, the company said on Thursday. Vertex said the study of VX-770 and VX-809 met ...
Vertex&#39;s promising CF drug combo clears first hurdle in Ph2FierceBiotech
Phase 2 Study of Two Potential CF Therapies — VX-770 and VX-809 — Shows ...PR Newswire (press release)
Interim Phase 2 Data Showed a Combination of VX-770 and VX-809 Improved ...Financial Post

all 20 news articles &raquo;